| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.07 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |